Results 161 to 170 of about 31,538 (351)

Tumor‐educated platelets in cancer diagnostics and prognostics: A critical appraisal and roadmap for clinical translation

International Journal of Cancer, EarlyView.
Abstract Tumor‐educated platelets (TEPs) are emerging as a compelling frontier in liquid biopsy, functioning as dynamic, systemic sensors that sequester and process tumor‐derived biomolecules. This interaction imprints an integrated molecular signature of malignancy—spanning the transcriptome, proteome, lipidome, and crucially, the captured genome ...
Whi‐An Kwon, Min‐Kyung Lee, Eunyong Ahn, Heeyeon Kim, Yong Sang Song, Taejin Ahn   +5 more
wiley   +1 more source

The hemostatic effects of Menaquinone-4 (K2) and other drugs on hemorrhage caused by hemorrhagenic agents with different mechanism in rats

, 1971
Tetsuya Tajima, Toshiharu OHGOH, Kohei MIYAO   +2 more
openalex   +2 more sources

MP63-14 ANTICIPATED POST-OPERATIVE RADIOGRAPHIC CHANGES OF HEMOSTATIC AGENTS IN PARTIAL NEPHRECTOMY [PDF]

, 2018
Ahmad M. El-Arabi, Ryan Tubre, Travis Dum, William P. Parker, Zachary Hamilton, Moben Mirza, David A. Duchêne   +6 more
openalex   +1 more source

Microsurgical intraluminal obliteration of type IV perimedullary arteriovenous fistula with an in situ hemostatic agent: illustrative case. [PDF]

J Neurosurg Case Lessons, 2023
Lara-Reyna J, Garst JR, Winslow N, Klopfenstein JD.   +3 more
europepmc   +1 more source

Comparative efficacy and safety of topical hemostatic agents in primary total knee arthroplasty

, 2021
Shaoshuo Li, Baixing Chen, Zhen Hua, Yang Shao, Heng Yin, Jianwei Wang   +5 more
openalex   +1 more source

Napabucasin transforms liver microenvironment and boosts immunotherapy efficacy by converting potential metastases into “hot” tumors

Interdisciplinary Medicine, EarlyView.
Napabucasin reduces liver metastases by reprogramming the hepatic microenvironment. It induces hepatocyte secretion of CCL21 via c‐Fos activation, recruiting lymphocytes and converting “cold” metastases into immunologically “hot” tumors. This effect is liver‐specific and independent of cancer cells.
Qiongqiong Wang, Jiaqi Zhou, Hang Qiao, Yifan Jia, Ling Ye, Zeli Li, Jiahe Ouyang, Haoxian Zhou, Kangxin Zeng, Xuemeng Wang, Yixian Wang, Yang Zhang, Yupeng Zhang, Yizhou Cai, Yutao Hu, Minzhe Zhang, Wenwei Xu, Zhenzhen Wu, Xiaofang Qiu, Li Lin   +19 more
wiley   +1 more source

Bond Strengths of Universal Adhesives to Dentin Contaminated with a Hemostatic Agent. [PDF]

J Adhes Dent, 2022
Noppawong S, Pratabsingha J, Thamsoonthorn C, Vichathai W, Saikaew P.   +4 more
europepmc   +1 more source

Evaluation of the biliostatic properties of modern topical hemostatic agents used in liver surgery

, 2018
Anna Vladimirovna Timoshenkova, Тимошенкова Анна Владимировна, Mihail Vladimirovich KuzminChuvash State University named after I.N. Ulyanov., Кузьмин Михаил Владимирович, Evgenyi Stepanovich Katanov, Катанов Евгений Степанович   +5 more
openalex   +2 more sources

Recent progress on stimuli‐responsive chitosan‐based biomaterials as drug carriers

Interdisciplinary Medicine, EarlyView.
This review discusses the recent progress in chitosan‐based drug delivery systems that respond to pH, redox, enzymes, reactive oxygen species, and combined stimuli. It examines design strategies, key mechanisms, and therapeutic applications, and also addresses current challenges while suggesting future approaches to enhance clinical translation and ...
Changlu Xu, Yi‐Tung Lu, Bin Yang, Zhi Li, Kui Zeng   +4 more
wiley   +1 more source

Clinical Interpretation of Platelet Activation Marker sCLEC‐2 in Antiphospholipid Syndrome

Journal of Clinical Laboratory Analysis, EarlyView.
Soluble C‐type lectin‐like receptor 2 (sCLEC‐2), a marker of platelet activation, was evaluated in patients with antiphospholipid syndrome (APS). Plasma sCLEC‐2 levels and the sCLEC‐2/D‐dimer ratio were significantly elevated in APS compared with other collagen diseases and healthy controls.
Risa Kaneshige, Yukari Motoki, Kiyoshi Ichihara, Junzo Nojima   +3 more
wiley   +1 more source